References
- Thomas E D, et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 1979; 301: 597–599
- Thomas E D, et al. Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 1979; 54: 468–476
- Barrett A J, et al. Bone marrow transplantation for acute lymphoblastic leukaemia. Br J Haematol 1982; 52: 181–188
- Johnson F L, et al. A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. N Engl J Med 1981; 305: 846–851
- Chessells J M, et al. Bone marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukaemia. Lancet 1986; i: 1239–1241
- Ringdén O, et al. Allogeneic bone marrow transplantation in children at Huddinge Hospital. Transplant Proc 1988; 20: 487–490
- Gustafsson G, Kreuger A. Prognosis after relapse in acute lymphoblastic leukemia in childhood. Pediatri Hematol Oncol 1986; 3: 119–126
- Riehm H, et al. The Berlin childhood acute lymphoblastic leukemia therapy study, 1970–1976. Am J Pediatr Hematol Oncol 1980; 2: 299–306
- Wollner N, et al. Non-Hodgkin's lymphoma in children. Cancer 1979; 44: 1990–1999
- Ringdén O, et al. A randomized trial comparing the use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematologic malignancies. Bone Marrow Transplant 1986; 1: 41–51
- Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
- O'Reilly R J, et al. Marrow transplantation for congenital disorders. Semin Hematol 1984; 21: 188–221
- Sanders J E, et al. Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: An update. Blood 1985; 66: 460–462
- Creutzig U, et al. Improved treatment results in childhood acute myelogenous leukemia: A report of the German Cooperative Study AML-BFM-78. Blood 1985; 65: 298–303
- Prentice H G, et al. Depletion of T lymphocytes in donor marrow prevents significant graft versus host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1984; i: 472–475
- Storb R, et al. Marrow transplantation for leukemia and aplastic anemia: Two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute grave-v-host disease. Transplant Proc 1987; 19: 2608–2613
- Mitsuyasu R T, et al. Treatment of donor bone marrow with monoclonal anti-t-cell antibody and complement for the prevention of graft-versus-host disease. Ann Intern Med 1986; 105: 20–26
- Gustafsson G, Kreuger A. Sex and other prognostic factors in acute lymphoblastic leukemia in childhood. Am J Pediatr Hematol Oncol 1983; 5: 243–250
- Cornbleet M A, Chessells J M. Bone marrow relapse in acute lymphoblastic leukemia in childhood. Br Med J 1978; 2: 104–106
- Butturini A, et al. Which treatment for childhood acute lymphoblastic leukaemia in second remission?. Lancet 1987; i: 429–432
- Barrett A J, et al. Prediction and prevention of relapse of acute lymphoblastic leukaemia after bone marrow transplantation. Br J Haematol 1986; 64: 179–186
- Bordigoni, et al. Allogeneic bone marrow transplantation in children with high risk acute lymphoblastic leukaemia—a study from GEGMO France. European Bone Marrow Transplant Meeting. ChemonixFrance 1988